These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 17879292)

  • 21. Comparison of a rational vs. high throughput approach for rapid salt screening and selection.
    Collman BM; Miller JM; Seadeek C; Stambek JA; Blackburn AC
    Drug Dev Ind Pharm; 2013 Jan; 39(1):29-38. PubMed ID: 22380522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An evaluation of salt screening methodologies.
    Fernández Casares A; Nap WM; Ten Figás G; Huizenga P; Groot R; Hoffmann M
    J Pharm Pharmacol; 2015 Jun; 67(6):812-22. PubMed ID: 25683791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipophilicity of basic drugs measured by hydrophilic interaction chromatography.
    Bard B; Carrupt PA; Martel S
    J Med Chem; 2009 May; 52(10):3416-9. PubMed ID: 19397318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination of inorganic pharmaceutical counterions using hydrophilic interaction chromatography coupled with a Corona CAD detector.
    Huang Z; Richards MA; Zha Y; Francis R; Lozano R; Ruan J
    J Pharm Biomed Anal; 2009 Dec; 50(5):809-14. PubMed ID: 19616396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An improved method for the characterization of supersaturation and precipitation of poorly soluble drugs using pulsatile microdialysis (PMD).
    Shah KB; Patel PG; Khairuzzaman A; Bellantone RA
    Int J Pharm; 2014 Jul; 468(1-2):64-74. PubMed ID: 24709210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Solubility prediction, solvate and cocrystal screening as tools for rational crystal engineering.
    Loschen C; Klamt A
    J Pharm Pharmacol; 2015 Jun; 67(6):803-11. PubMed ID: 25851032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Salt formation to improve drug solubility.
    Serajuddin AT
    Adv Drug Deliv Rev; 2007 Jul; 59(7):603-16. PubMed ID: 17619064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A high throughput dried DMSO LogD lipophilicity measurement based on 96-well shake-flask and atmospheric pressure photoionization mass spectrometry detection.
    Alelyunas YW; Pelosi-Kilby L; Turcotte P; Kary MB; Spreen RC
    J Chromatogr A; 2010 Mar; 1217(12):1950-5. PubMed ID: 20153476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of pharmaceutical salts and cocrystals to address the issue of poor solubility.
    Elder DP; Holm R; Diego HL
    Int J Pharm; 2013 Aug; 453(1):88-100. PubMed ID: 23182973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved group contribution parameter set for the application of solubility parameters to melt extrusion.
    Just S; Sievert F; Thommes M; Breitkreutz J
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1191-9. PubMed ID: 23628829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure, solubility, screening, and synthesis of molecular salts.
    Black SN; Collier EA; Davey RJ; Roberts RJ
    J Pharm Sci; 2007 May; 96(5):1053-68. PubMed ID: 17455329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of chromatographic and spectroscopic methods used to rank compounds for aqueous solubility.
    Pan L; Ho Q; Tsutsui K; Takahashi L
    J Pharm Sci; 2001 Apr; 90(4):521-9. PubMed ID: 11170041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of a high-throughput screening method for the detection of the excipient-mediated precipitation inhibition of poorly soluble drugs.
    Petruševska M; Urleb U; Peternel L
    Assay Drug Dev Technol; 2013 Mar; 11(2):117-29. PubMed ID: 23116459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Automated robotic liquid handling/laser-based nephelometry system for high throughput measurement of kinetic aqueous solubility.
    Dehring KA; Workman HL; Miller KD; Mandagere A; Poole SK
    J Pharm Biomed Anal; 2004 Nov; 36(3):447-56. PubMed ID: 15522517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro methods to assess drug precipitation.
    Dai WG
    Int J Pharm; 2010 Jun; 393(1-2):1-16. PubMed ID: 20347943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of a high-throughput screening procedure with PEG-induced precipitation to compare relative protein solubility during formulation development with IgG1 monoclonal antibodies.
    Gibson TJ; Mccarty K; Mcfadyen IJ; Cash E; Dalmonte P; Hinds KD; Dinerman AA; Alvarez JC; Volkin DB
    J Pharm Sci; 2011 Mar; 100(3):1009-21. PubMed ID: 21280052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of pH-dependent aqueous solubility of druglike molecules.
    Hansen NT; Kouskoumvekaki I; Jørgensen FS; Brunak S; Jónsdóttir SO
    J Chem Inf Model; 2006; 46(6):2601-9. PubMed ID: 17125200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Application of a Dried-DMSO rapid throughput 24-h equilibrium solubility in advancing discovery candidates.
    Alelyunas YW; Liu R; Pelosi-Kilby L; Shen C
    Eur J Pharm Sci; 2009 May; 37(2):172-82. PubMed ID: 19429424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids.
    Morissette SL; Almarsson O; Peterson ML; Remenar JF; Read MJ; Lemmo AV; Ellis S; Cima MJ; Gardner CR
    Adv Drug Deliv Rev; 2004 Feb; 56(3):275-300. PubMed ID: 14962582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Application of high-throughput technologies in pharmaceutics].
    Bai XL; Gao YL
    Yao Xue Xue Bao; 2006 Jun; 41(6):487-92. PubMed ID: 16927820
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.